Bioatla Inc (BCAB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.89M
Last updated: Nov 16, 2026 at 4:00 PM ET
Bioatla Inc (BCAB) Stock Chart
Bioatla (BCAB) closed at $1.99 on Nov 16, 2026, 97.2% below its 52-week high of $71.50. Its price fell 94.0% over the past 12 months. The month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 73.0%.
Price Chart
From Dec 2020 to Oct 2026, its highest month-end close was $2,655.00 in Feb 2021 and its lowest $1.30 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BCAB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BCAB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 37.4%, and over 6 months it fell 49.2%. The month-end price fell 97.1% over the 3 years through Oct 2026, a compound annual decline of 69.4%.
| Period | Change |
|---|---|
| 1 month | +46.3% |
| 3 months | -37.4% |
| 6 months | -49.2% |
| 12 months | -94.0% |
| 12 months, with dividends | -94.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -97.1% | -69.4% |
| 5 years | -99.9% | -73.0% |
Price by Year
Its best calendar year was 2025, when the price fell 4.0%, and its weakest was 2024, when it fell 76.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.10 | -92.6% |
| 2025 | $28.39 | -4.0% |
| 2024 | $29.56 | -76.0% |
| 2023 | $123.00 | -70.2% |
| 2022 | $412.50 | -58.0% |
| 2021 | $981.50 | -42.3% |
Trading Range
The price is 22.5% above its 50-day average of $1.63 and 53.7% below its 200-day average of $4.30.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $1.99 | |
| 52-week high | $71.50 | -97.2% |
| 52-week low | $1.07 | +86.0% |
| 50-day average | $1.63 | +22.5% |
| 200-day average | $4.30 | -53.7% |
Price Risk
Over 3 years, its largest fall from a peak was 99.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.26 |
| Largest fall, 1 year | -98.2% |
| Largest fall, 3 years | -99.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BCAB
What is BCAB's 1-year price change?
Bioatla's price fell 94.0% over the past 12 months. With dividends included, the 12-month total return was -94.0%.
What is BCAB's 5-year price change?
Bioatla's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 73.0%. These figures leave out dividends.
What is BCAB's 52-week high and low?
Bioatla's 52-week high is $71.50 and its 52-week low is $1.07. Its close of $1.99 on Nov 16, 2026 is 97.2% below the high.
What is BCAB's beta?
Bioatla's 1-year beta against the S&P 500 is 0.26, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 98.2%.
Is the BCAB chart free?
Yes. Advanced Charting for BCAB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BCAB pages: Overview, Charting, Earnings, Financials, Statistics, Competitors